Last reviewed · How we verify
Medium dose of quadrivalent VLP vaccine
Medium dose of quadrivalent VLP vaccine is a Biologic drug developed by Medicago. It is currently in Phase 2 development.
At a glance
| Generic name | Medium dose of quadrivalent VLP vaccine |
|---|---|
| Sponsor | Medicago |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults (PHASE1, PHASE2)
- Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults (PHASE2)
- Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population (PHASE2)
- Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults (PHASE2)
- A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young Adults (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Medium dose of quadrivalent VLP vaccine CI brief — competitive landscape report
- Medium dose of quadrivalent VLP vaccine updates RSS · CI watch RSS
- Medicago portfolio CI
Frequently asked questions about Medium dose of quadrivalent VLP vaccine
What is Medium dose of quadrivalent VLP vaccine?
Medium dose of quadrivalent VLP vaccine is a Biologic drug developed by Medicago.
Who makes Medium dose of quadrivalent VLP vaccine?
Medium dose of quadrivalent VLP vaccine is developed by Medicago (see full Medicago pipeline at /company/medicago).
What development phase is Medium dose of quadrivalent VLP vaccine in?
Medium dose of quadrivalent VLP vaccine is in Phase 2.